title: Rutile TiO₂ particles exert size and surface coating dependent retention and lesions on the murine brain.
abstract: The rising commercial use and large-scale production of engineered nanoparticles (NPs) may lead to unintended exposure to humans. The central nervous system (CNS) is a potential susceptible target of the inhaled NPs, but so far the amount of studies on this aspect is limited. Here, we focus on the potential neurological lesion in the brain induced by the intranasally instilled titanium dioxide (TiO₂) particles in rutile phase and of various sizes and surface coatings. Female mice were intranasally instilled with four different types of TiO₂ particles (i.e. two types of hydrophobic particles in micro- and nano-sized without coating and two types of water-soluble hydrophilic nano-sized particles with silica surface coating) every other day for 30 days. Inductively coupled plasma mass spectrometry (ICP-MS) were used to determine the titanium contents in the sub-brain regions. Then, the pathological examination of brain tissues and measurements of the monoamine neurotransmitter levels in the sub-brain regions were performed. We found significant up-regulation of Ti contents in the cerebral cortex and striatum after intranasal instillation of hydrophilic TiO₂ NPs. Moreover, TiO₂ NPs exposure, in particular the hydrophilic NPs, caused obvious morphological changes of neurons in the cerebral cortex and significant disturbance of the monoamine neurotransmitter levels in the sub-brain regions studied. Thus, our results indicate that the surface modification of the NPs plays an important role on their effects on the brain. In addition, the difference in neurotoxicity of the two types of hydrophilic NPs may be induced by the shape differences of the materials. The present results suggest that physicochemical properties like size, shape and surface modification of the nanomaterials should be considered when evaluating their neurological effects.
authors.affiliation: CAS Key Lab for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology, Beijing 100190, China.
authors.forename: Lili
authors.initials: L
authors.lastname: Zhang
authors.forename: Ru
authors.initials: R
authors.lastname: Bai
authors.forename: Bai
authors.initials: B
authors.lastname: Li
authors.forename: Cuicui
authors.initials: C
authors.lastname: Ge
authors.forename: Jiangfeng
authors.initials: J
authors.lastname: Du
authors.forename: Ying
authors.initials: Y
authors.lastname: Liu
authors.forename: Laurent
authors.initials: L
authors.lastname: Le Guyader
authors.forename: Yuliang
authors.initials: Y
authors.lastname: Zhao
authors.forename: Yanchuan
authors.initials: Y
authors.lastname: Wu
authors.forename: Shida
authors.initials: S
authors.lastname: He
authors.forename: Yongmei
authors.initials: Y
authors.lastname: Ma
authors.forename: Chunying
authors.initials: C
authors.lastname: Chen
mesh_terms: D000281:Administration, Intranasal; D000818:Animals; D001921:Brain / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D001927:Brain Diseases / Q000139:chemically induced* / Q000378:metabolism / Q000473:pathology; D004298:Dopamine / Q000032:analysis / Q000378:metabolism*; D005260:Female; D006651:Histocytochemistry; D051379:Mice; D008813:Mice, Inbred ICR; D008855:Microscopy, Electron, Scanning; D046529:Microscopy, Electron, Transmission; D053758:Nanoparticles / Q000633:toxicity*; D010316:Particle Size; D011897:Random Allocation; D013499:Surface Properties; D014025:Titanium / Q000493:pharmacokinetics / Q000633:toxicity*
chemical_list: C009495:titanium dioxide; D014025:Titanium; D004298:Dopamine